Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


880 Stroke Patients in Singapore to Undergo TCM Clinical Trial (Singapore)

This article was originally published in PharmAsia News

Executive Summary

Singapore's National Medical Research Council has initiated the world's largest recorded clinical trial to test a stroke recovery treatment. Over the course of two years, researchers will evaluate the effectiveness of a traditional Chinese medicine known as NeuroAid on patients who have suffered a stroke in the past 48 hours. Neuroaid is already used around the world to support neurological performance. The study will include 1,100 subjects including 880 from Singapore itself. Additional patients will come from Thailand, the Philippines, and possibly Hong Kong. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts